These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 22493358)
21. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles. Benfer M; Kissel T Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653 [TBL] [Abstract][Full Text] [Related]
22. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264 [TBL] [Abstract][Full Text] [Related]
23. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis. Lee H; Kim IK; Park TG Bioconjug Chem; 2010 Feb; 21(2):289-95. PubMed ID: 20078095 [TBL] [Abstract][Full Text] [Related]
24. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Katas H; Cevher E; Alpar HO Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405 [TBL] [Abstract][Full Text] [Related]
25. Non-covalent Nanocomplexes of Folic Acid and Reducible Polyethylenimine for Survivin siRNA Delivery. Zheng B; Yang S; Wang M; Yang X; Teng L; Xie J; Teng L; Lee RJ Anticancer Res; 2015 Oct; 35(10):5433-41. PubMed ID: 26408706 [TBL] [Abstract][Full Text] [Related]
26. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Park K; Lee MY; Kim KS; Hahn SK Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167 [TBL] [Abstract][Full Text] [Related]
27. Binary and ternary complexes based on polycaprolactone-graft-poly (N, N-dimethylaminoethyl methacrylate) for targeted siRNA delivery. Huang Y; Lin D; Jiang Q; Zhang W; Guo S; Xiao P; Zheng S; Wang X; Chen H; Zhang HY; Deng L; Xing J; Du Q; Dong A; Liang Z Biomaterials; 2012 Jun; 33(18):4653-64. PubMed ID: 22480869 [TBL] [Abstract][Full Text] [Related]
28. Mono-methoxy-poly(3-hydroxybutyrate-co-4-hydroxybutyrate)-graft-hyper-branched polyethylenimine copolymers for siRNA delivery. Zhou L; Chen Z; Chi W; Yang X; Wang W; Zhang B Biomaterials; 2012 Mar; 33(7):2334-44. PubMed ID: 22154621 [TBL] [Abstract][Full Text] [Related]
29. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738 [TBL] [Abstract][Full Text] [Related]
30. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. Lee Y; Lee SH; Kim JS; Maruyama A; Chen X; Park TG J Control Release; 2011 Oct; 155(1):3-10. PubMed ID: 20869409 [TBL] [Abstract][Full Text] [Related]
31. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro. Nie C; Liu C; Chen G; Dai J; Li H; Shuai X J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388 [TBL] [Abstract][Full Text] [Related]
32. PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro. Weber ND; Merkel OM; Kissel T; Muñoz-Fernández MÁ J Control Release; 2012 Jan; 157(1):55-63. PubMed ID: 21930169 [TBL] [Abstract][Full Text] [Related]
33. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348 [TBL] [Abstract][Full Text] [Related]
34. Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier. Kang JH; Tachibana Y; Kamata W; Mahara A; Harada-Shiba M; Yamaoka T Bioorg Med Chem; 2010 Jun; 18(11):3946-50. PubMed ID: 20472444 [TBL] [Abstract][Full Text] [Related]
35. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes. Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615 [TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Kim SH; Mok H; Jeong JH; Kim SW; Park TG Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275 [TBL] [Abstract][Full Text] [Related]
37. 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo. Goyal R; Bansal R; Tyagi S; Shukla Y; Kumar P; Gupta KC Mol Biosyst; 2011 Jun; 7(6):2055-65. PubMed ID: 21505659 [TBL] [Abstract][Full Text] [Related]
38. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588 [TBL] [Abstract][Full Text] [Related]